Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | CDC14B | O60729 | 3/20 | 0.35 |
| ▸ | CDC14A | Q9UNH5 | 3/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | PRKDC | P78527 | 7/20 | 0.34 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22523527 | 0.94 | ALOX5 (0.45) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL23438651 | 0.92 | ALOX5 (0.45) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL23313696 | 0.92 | ALOX5 (0.45) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL23313945 | 0.92 | ALOX5 (0.45) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL24999272 | 0.91 | ALOX5 (0.44) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL23438326 | 0.91 | ALOX5 (0.44) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL22523222 | 0.91 | ALOX5 (0.47) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL22523342 | 0.91 | ALOX5 (0.47) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL25621484 | 0.91 | ALOX5 (0.40) | ALOX5CDC14BCDC14AGGPS1PRKDC | |
| SCHEMBL22523457 | 0.90 | ALOX5 (0.45) | ALOX5CDC14BCDC14AGGPS1PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210126197-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210126197-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, L1CAM, AOC1 | ALOX5 1383/4885CDC14B 3733/4885CDC14A 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.